Home › Funds › Sio Capital Management, LLC › IBIO

Sio Capital Management, LLC position in IBIO

IBIO INC · Health Care

Sio Capital Management, LLC reported holding 904,268 shares of IBIO (IBIO INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 0.26% of its reported portfolio and ranking #48 among its reported holdings. Sio Capital Management, LLC has disclosed IBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)904.27K sh
Reported value held$1.58M
Portfolio Weight0.26%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's IBIO position evolved

Sio Capital Management, LLC first disclosed a stake in IBIO in Q4 2025 at 740,000 shares (US$1.4M). The position peaked in Q1 2026 at 904,268 shares, worth US$1.7M. Across 3 filings, Sio Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 904,268 shares valued at US$1.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 740.00K $1.43M New
Q1 2026 904.27K $1.72M Add
Q2 2026 904.27K $1.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBIO and 13F data

IBIO (IBIO INC) is a Health Care company. 44 other funds we track also report a position in IBIO — the largest reported positions include Cormorant Asset Management, LP (US$6.2M), SILVERARC CAPITAL MANAGEMENT, LLC (US$6.2M), Frazier Life Sciences Management, L.P. (US$3.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBIO

All IBIO fund holders →

FAQ

How long has Sio Capital Management, LLC held IBIO?

Sio Capital Management, LLC has disclosed IBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Sio Capital Management, LLC's current position in IBIO?

As of Q2 2026, Sio Capital Management, LLC holds 904.27K shares of IBIO (IBIO INC), valued at $1.58M, representing 0.26% of its reported portfolio and ranking #48.

Has Sio Capital Management, LLC been buying or selling IBIO?

In the latest 13F filing (Q2 2026), Sio Capital Management, LLC held unchanged its position in IBIO. The position peaked in Q1 2026 at 904.27K shares.

Which other funds hold IBIO?

Other major institutional holders of IBIO include Cormorant Asset Management, LP, SILVERARC CAPITAL MANAGEMENT, LLC, Frazier Life Sciences Management, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.